News tagged with plavix
Clopidogrel with aspirin doesn't prevent more small strokes, may increase risk of bleeding, death
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according ...
Medicine & Health / Cardiology
Feb 03, 2012 |
not rated yet |
0
Allergy to Plavix can be overcome: study
Allergies to Plavix, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary ...
Medicine & Health / Medications
Jan 16, 2012 |
not rated yet |
0
Genetic test for Plavix use may be unneeded: study
A new study published Wednesday cast doubt on the usefulness of a genetic test for patients taking the anti-coagulant drug Plavix, calling into question last year's FDA warning about the blood thinner.
Medicine & Health / Medications
Dec 29, 2011 |
not rated yet |
0
Impact of timing on carotid artery stenting after stroke or transient ischemic attack
A recent study found no significant difference in the outcome for patients who received carotid artery stenting (CAS) at more than 30 days post-transient ischemic attack (TIA) or stroke versus those who received CAS at 30 ...
Medicine & Health / Cardiology
Nov 14, 2011 |
not rated yet |
0
World's first bedside genetic test proves effective
Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...
Nov 09, 2011 |
not rated yet |
0
|
Anti-clotting drugs do not increase bleeding risk in GI procedure, study finds
Patients with recent use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDS), or anti-clotting drugs such as clopidogreal (Plavix) do not appear to have an increased risk of bleeding during or after removal of precancerous ...
Medicine & Health / Cardiology
Nov 01, 2011 |
not rated yet |
0
Drug prices to plummet in wave of expiring patents
The cost of prescription medicines used by millions of people every day is about to plummet. The next 14 months will bring generic versions of seven of the world's 20 best-selling drugs, including the top ...
Medicine & Health / Medications
Jul 25, 2011 |
5 / 5 (3) |
4
FDA extends Plavix patent by 6 months to May 2012
(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.
Medicine & Health / Medications
Jan 25, 2011 |
not rated yet |
1
Bristol-Myers Squibb sees 3Q profit dip 2 percent
(AP) -- Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government ...
Oct 26, 2010 |
not rated yet |
0
Study contradicts reports of problems with blood-thinner
New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.
Medicine & Health / Medications
Aug 29, 2010 |
not rated yet |
0
Plavix may be treatment for dogs at risk of thromboembolic disease
Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.
Jul 14, 2010 |
not rated yet |
0
FDA warning: some patients cannot process Plavix
(AP) -- The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.
Medicine & Health / Medications
Mar 12, 2010 |
4.3 / 5 (3) |
1
Drug ads ineffective for boosting sales, could cost taxpayers: study
US Taxpayers may be on the hook for the high cost of drug advertising that does little to boost sales, according to a new study led by a University of British Columbia health policy researcher.
Nov 23, 2009 |
not rated yet |
0
FDA says heartburn drugs can interfere with Plavix
(AP) -- Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack ...
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
(PhysOrg.com) -- Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked ...
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
Clopidogrel
Clopidogrel is an oral antiplatelet agent (thienopyridine class) to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix, by Sun Pharmaceuticals under the trade name Clopilet, by Ranbaxy Laboratories under the trade name Ceruvin. It works by irreversibly inhibiting a receptor called P2Y12. Adverse effects include hemorrhage.
For more information about Clopidogrel, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
